Is performing lobectomy after the use of bevacizumab for a lung tumor dangerous?

Ann Med Surg (Lond)

Department of Thoracic Surgery, Saitama Cancer Center, 780 Komuro, Ina, Kita-adachi-gun, Saitama 362-0806, Japan.

Published: March 2016

Recent new drugs, such as bevacizumab (Bev), also result in a remarkable response. However, the safety of major lung resection after the use of Bev remains controversial. Is it really dangerous to perform major lung resection after the use of Bev for a lung tumor? In this report, we describe two patients who underwent surgery safely without fragile pathological findings of the vessels.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843098PMC
http://dx.doi.org/10.1016/j.amsu.2016.01.081DOI Listing

Publication Analysis

Top Keywords

major lung
8
lung resection
8
resection bev
8
performing lobectomy
4
lobectomy bevacizumab
4
lung
4
bevacizumab lung
4
lung tumor
4
tumor dangerous?
4
dangerous? drugs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!